MARIA TEDI CORONEL: Open Payments
NPI 1558848218 · HACKENSACK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,336 in 134 payments from 18 companies in 2025. Trend: 2023 $6,746 · 2024 $4,428 · 2025 $4,336
Food & beverage: $4,174Education: $162
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $813 |
| ABBVIE INC. | 26 | $659 |
| Biogen, Inc. | 5 | $432 |
| Janssen Scientific Affairs, LLC | 6 | $430 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $347 |
| Amgen Inc. | 2 | $263 |
| Alexion Pharmaceuticals, Inc. | 2 | $250 |
| Novo Nordisk Inc | 4 | $181 |
| Ipsen Biopharmaceuticals, Inc | 6 | $160 |
| Celltrion USA Inc. | 17 | $144 |
Products named: TREMFYA, TYSABRI, ENTYVIO, SKYRIZI, RINVOQ, ULTOMIRIS, Wegovy, IQIRVO.
Industry payments across NJ — which companies pay providers there.
